Document Detail


An increase in low aortic pressure increases coronary artery flow and coronary thrombolysis induced by intravenous administration of recombinant tissue plasminogen activator.
MedLine Citation:
PMID:  7757138     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Our study investigated the effects of an increase in aortic pressure, induced by norepinephrine (NE) administration on coronary artery flow in a clotted artery, and rate of coronary thrombolysis induced by intravenous (i.v.) administration of recombinant tissue plasminogen activator (rtPA). METHODS: A canine model of coronary thrombosis, induced by intracoronary injection of radioactive autologous blood clots, was used to test the hypothesis that an increase in aortic blood pressure will increase coronary artery flow and the rate of clot lysis induced by i.v. administration of rtPA. RESULTS: After clot injection, 11 dogs were phlebotomized to decrease systolic aortic pressure to 75 mm Hg. Subsequently, .25 mg/kg of rtPA was administered intravenously over two 15-minute intervals, one during hypotension, and the other after NE infusion had increased systolic blood pressure to 130 mm Hg. In six dogs the hypotensive condition was studied first, and in five dogs the NE-induced normotensive condition was studied first. In all dogs, coronary artery flow and the rate of clot lysis were significantly increased in the normotensive condition. CONCLUSIONS: These results indicate that an increase in a low coronary artery perfusion pressure may enhance coronary artery flow and the rate of thrombolysis.
Authors:
P J Garber; S Gu; J Ducas; U Schick; R M Prewitt
Related Documents :
6421078 - Nitrous oxide augments the systemic and coronary haemodynamic effects of isoflurane in ...
15653018 - Pressure-derived measurement of coronary flow reserve.
2813558 - Responses of the working rat heart to carbon monoxide.
8873658 - Simultaneous coronary pressure and flow velocity measurements in humans. feasibility, r...
1860708 - Reversal of low dose angiotension hypertension by angiotensin receptor antagonists.
16936438 - Upregulated neurohumoral factors are associated with left ventricular remodeling and po...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of critical care     Volume:  10     ISSN:  0883-9441     ISO Abbreviation:  J Crit Care     Publication Date:  1995 Mar 
Date Detail:
Created Date:  1995-06-27     Completed Date:  1995-06-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8610642     Medline TA:  J Crit Care     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Manitoba, Health Sciences Centre, Winnipeg, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aorta / drug effects,  physiology*
Blood Pressure / drug effects,  physiology*
Coronary Circulation / drug effects,  physiology*
Coronary Thrombosis / drug therapy,  physiopathology
Disease Models, Animal
Dogs
Drug Evaluation, Preclinical
Drug Therapy, Combination
Infusions, Intravenous
Norepinephrine / administration & dosage
Recombinant Proteins / administration & dosage
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / administration & dosage*
Chemical
Reg. No./Substance:
0/Recombinant Proteins; 51-41-2/Norepinephrine; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The discovery of a fertilizing substance in the air
Next Document:  Effect of infusion and withdrawl of glucose and insulin on gas exchange in injured ventilated patien...